EZH2-EED inhibitors (OncoFusion)

N/A

Report date: 2025/03/20 16:00:13
NME

Base Information

Drug NameEZH2-EED inhibitors (OncoFusion)
Drug Alias NameN/A
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionHistone-lysine N-methyltransferase EZH2 inhibitorsPolycomb protein EED inhibitors
TargetsHistone-lysine N-methyltransferase EZH2Polycomb protein EED
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesOncoFusion Therapeutics
China Registration ClassN/A

Develop Information

Active CompaniesOncoFusion Therapeutics
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A